Advertisement

Growth Factors, Oncogenes and Tumour Suppressor Genes

  • D. P. Hollywood
  • N. R. Lemoine

Abstract

Control of cell proliferation involves a complex interplay between direct mechanisms linking a cell with adjacent cells and their interstitial stroma, and indirect mechanisms mediated through factors carried by organ vasculature. Disruption of the functional integrity of growth regulatory systems may lead to uncontrolled proliferation and abnormal cellular behaviour manifest in a most extreme form in the development of malignant tumours.

Keywords

Serum Response Factor SteroId Hormone Human Breast Carcinoma Cell Line Serum Response Element Tumour Suppressor Gene Product 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Almendral JM, Sommer D, Macdonald-Bravo H, Burckhardt J, Perera J and Bravo R (1988) Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol 8:2140–2148PubMedGoogle Scholar
  2. Battegay EJ, Raines EW, Siefert RA, Bowen-Pope DF and Ross R (1990) TGFb induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515–524PubMedCrossRefGoogle Scholar
  3. Benbrook DM and Jones NC (1990) Heterodimer formation between CREB and JUN proteins. Oncogene 5:295–305PubMedGoogle Scholar
  4. Berg JM (1989) DNA binding specificity of steroid receptors. Cell 57:1065–1068PubMedCrossRefGoogle Scholar
  5. Bos J (1989) ras oncogenes in human cancer: a review. Cancer Res 49:4682–4689PubMedGoogle Scholar
  6. Bravo R (1990) Genes induced during the Go/Gj transition in mouse fibroblasts. Semin Cancer Biol 1:37–46PubMedGoogle Scholar
  7. Burns CP and Rozengurt E (1984) Extracellular Na+ and initiation of DNA synthesis: role of intracellular pH and K+. J Cell Biol 98:1082–1089PubMedCrossRefGoogle Scholar
  8. Carpenter G (1987) Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 56:81–91CrossRefGoogle Scholar
  9. Cho-Chung YS (1990) Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res 50:7093–7100PubMedGoogle Scholar
  10. Cole MD (1986) The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 20:361–386PubMedCrossRefGoogle Scholar
  11. Cordingley MG, Riegel AT and Hager GL (1987) Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumour virus in vitro. Cell 48:261–270PubMedCrossRefGoogle Scholar
  12. Curran T and Franza Jr BR (1988) Fos and Jun: the API connection. Cell 55:395–397PubMedCrossRefGoogle Scholar
  13. DeCaprio J A, Ludlow JW and Lynch D, et al. (1989) The product of the retinoblastoma gene has properties of a cell cycle regulatory element. Cell 58:1085–1095PubMedCrossRefGoogle Scholar
  14. Diamond MI, Miner JN, Yoshinaga SK and Yamamoto KR (1990) Transcription factor interactions: selectors of positive and negative regulation from a single DNA element. Science 249: 1266–1272PubMedCrossRefGoogle Scholar
  15. Diller L, Kassel J and Nelson CE, et al. (1990) p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 11:5752–5781Google Scholar
  16. Downward J, Graves JD, Warne PH, Rayter S and Cantrell DA (1990) Stimulation of p21ras upon T-cell activation. Nature 346:719–723PubMedCrossRefGoogle Scholar
  17. Dumont JE, Jauniaux JC and Roger PP (1989) The cyclic AMP-mediated stimulation of cell proliferation. TIBS 114:67–70Google Scholar
  18. Edelman AM, Blumenthal DK and Krebs EG (1987) Protein serine/threonine kinases. Ann Rev Biochem 56:567–613PubMedCrossRefGoogle Scholar
  19. Eliyahu D, Michalovitch D and Oren M (1985) Overproduction of p53 antigen makes established cell highly tumorigenic. Nature 316:158–160PubMedCrossRefGoogle Scholar
  20. Evans G (1990) The myc oncogene. In: Carney D, Sikora K (eds) Genes and cancer. John Wiley amp Sons Ltd, Chichester, pp 31–43Google Scholar
  21. Fearon ER and Vogelstein B (1990) A genetic model of colorectal carcinogenesis. Cell 61:759–767PubMedCrossRefGoogle Scholar
  22. Finlay CA, Hinds PW and Levine A J (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083–1093PubMedCrossRefGoogle Scholar
  23. Fontana JA, Miranda D and Burrows-Mezu A (1990) Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by inhibition of the synthesis of a Mr 39000 protein. Cancer Res 50:1977–1982PubMedGoogle Scholar
  24. Gai X, Rizzo MG, Lee J, Ullrich A and Beserga R (1988) Abrogation of the requirements for added growth factors in 3T3 cells constitutively expressing the p53 and the IFF-1 genes. Oncogene Res 3:377–386PubMedGoogle Scholar
  25. Gospodarowicz D, Neufield G and Schwiegerer L (1987) Fibroblast growth factor: structure and biological properties. J Cell Phys Suppl 5:15–26CrossRefGoogle Scholar
  26. Heldin CH and Westermark B (1989) Growth factors as transforming proteins. Eur J Biochem 184:487–496PubMedCrossRefGoogle Scholar
  27. Horowitz JM, Park SH and Bogenmann E, et al. (1990) Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumour cells. Proc Natl Acad Sci (USA) 87:2775–2779CrossRefGoogle Scholar
  28. Kaplan DR, Whitman D and Schaffhausen B, et al. (1987) Common elements in growth factor stimulation and oncogenic transformation: 85 kD phosphoprotein and phosphatidylinositol kinase activity. Cell 50:1021–1029PubMedCrossRefGoogle Scholar
  29. Karin M (1989) Complexities of gene regulation by cAMP. TIBS 5:65–67Google Scholar
  30. Knabbe CME, Lippman ME and Wakefield LM, et al. (1987) Evidence that transforming factorbeta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417–428PubMedCrossRefGoogle Scholar
  31. Kypta RM, Goldberg Y, Ulug ET and Courtneidge SA (1990) Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 62:481–492PubMedCrossRefGoogle Scholar
  32. Lamph WW, Wamsley P, Sassone-Corsi P and Vermi IM (1988) Induction of proto-oncogene JUN/AP1 by serum and TP A. Nature 334:629–634PubMedCrossRefGoogle Scholar
  33. Margolis B, Rhee SG and Felder S, et al. (1990) EGF induces phosphorylation of phospholipase C: a potential mechanism for EGF receptor signalling. Cell 57:1101–1107CrossRefGoogle Scholar
  34. Miesenhelder J, Suh PG, Rhee SG and Hunter T (1989) PhospholipaseC-y is a substrate for the PDGF and EGF receptor protein tyrosine kinases in vivo and in vitro. Cell 57:1109–1122CrossRefGoogle Scholar
  35. Molloy CJ, Bottaro DP, Fleming TP, Marshall MS, Gibbs JB and Aaronson S (1989) PDGF induction of tyrosine phosphorylation of GTPase activating protein. Nature 342:711–714PubMedCrossRefGoogle Scholar
  36. Moody TW, Pert CB, Gazdar AF, Carney DN and Minna JD (1981) High levels of intracellular bombesin characterize human small cell carcinoma cell lines. Science 214:1246PubMedCrossRefGoogle Scholar
  37. Morrison DK, Kaplan DR, Escobedo JA, Rapp UR, Roberts TM and Williams LT (1989) Direct activation of the serine-threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF B-receptor. Cell 58:649–657PubMedCrossRefGoogle Scholar
  38. Moses HL, Yang EY and Pietenpol JA (1990) TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245–247PubMedCrossRefGoogle Scholar
  39. Muller R, Bravo R, Burckhardt J and Curran T (1984) Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature 312:716–718PubMedCrossRefGoogle Scholar
  40. Nishizuka Y (1986) Studies and perspectives of protein kinase C. Science 233:305–311PubMedCrossRefGoogle Scholar
  41. Nishizuka Y (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334:661–668PubMedCrossRefGoogle Scholar
  42. Ong G, Sikora K and Gullick WJ (1991) Inactivation of the retinoblastoma gene does not lead to loss of TGFβ receptor or loss of response to TGFβ in breast cancer cell lines. Oncogene (in press)Google Scholar
  43. Pardee AB (1989) G1 events and regulation of cell proliferation. Science 246:603–608PubMedCrossRefGoogle Scholar
  44. Quayum A, Gullick WJ, Clayton RC, Sikora K and Waxman J (1990) High affinity receptors for gonadotrophin-releasing hormone are present in human prostate cancer. Br J Cancer 62:96–99CrossRefGoogle Scholar
  45. Rauscher III FJ, Morris JF, Tournay OE, Cook DM and Curran T (1990) Binding of the Wilms’ tumour locus zinc finger protein to the EGR-1 consensus sequence. Science 250:1259–1262PubMedCrossRefGoogle Scholar
  46. Rayter SI, Iwata KK, Michitsch RW, Sorvillo JM, Valenzuela DM and Foulkes JG (1989) Biochemical function of oncogenes. In: Glover DM, Hames BD (eds) Oncogenes. Oxford University Press, Oxford, pp 113–189Google Scholar
  47. Robey PG, Young MF and Flanders KC, et al. (1987) Osteoblasts synthesize and respond to TGF-beta in vitro. J Cell Biol 105:457–463PubMedCrossRefGoogle Scholar
  48. Rozengurt E (1986) Early signals in the mitogenic response. Science 234:161–166PubMedCrossRefGoogle Scholar
  49. Russell P and Nurse P (1986) cdc25 + functions as an inducer in mitotic control of fission yeast. Cell 45:145–153PubMedCrossRefGoogle Scholar
  50. Shaw PE, Schroter H and Nordheim A (1989a) The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter. Cell 56:563–572PubMedCrossRefGoogle Scholar
  51. Shaw PE, Frasch S and Nordheim A (1989b) Repression of c-fos transcription is mediated through p67SRF bound to the SRE. EMBO J 8:2567–2574Google Scholar
  52. Shohat O, Greenberg M, Reisman D, Oren M and Rotter V (1987) Inhibition of cell growth mediated by plasmids encoding p53 anti-sense. Oncogene 1:277–283PubMedGoogle Scholar
  53. Silberstein GB and Daniel CW (1987) Reversible inhibition of mammary gland growth by transforming growth factor p. Science 237:291–293PubMedCrossRefGoogle Scholar
  54. Sporn MB and Todaro GJ (1989) Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878–880CrossRefGoogle Scholar
  55. Treisman R (1990) The SRE: a growth factor responsive transcriptional regulator. Semin Cancer Biol 1:47–58PubMedGoogle Scholar
  56. Ullrich A and Schlessinger J (1989) Signal transduction by receptors with tyrosine kinase activity. Cell 61:203–212CrossRefGoogle Scholar
  57. Weinstein BI (1988) The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment - Twenty-seventh G.H. A. Clowes Memorial Award Lecture. Cancer Res 48:4135–4143PubMedGoogle Scholar
  58. Wilkinson DG, Bhatt S, Ryseck R-P and Bravo R (1989) Tissue specific expression of c-jun and jun-B during organogenesis in the mouse. Development 106:465–471PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1992

Authors and Affiliations

  • D. P. Hollywood
  • N. R. Lemoine

There are no affiliations available

Personalised recommendations